key: cord-1047540-fegamaz0 authors: Ong, Kimberly Mae C.; Cruz, Teresa Luisa G. title: Otologic and vestibular symptoms in COVID‐19: A scoping review date: 2022-04-06 journal: World J Otorhinolaryngol Head Neck Surg DOI: 10.1002/wjo2.57 sha: f2d49f6a2c4926f044d20b46621b4882f566e19d doc_id: 1047540 cord_uid: fegamaz0 BACKGROUND: Otologic and vestibular symptoms have been seen in patients confirmed to have COVID‐19 disease. Further discussion of these symptoms may provide insight into short‐ and long‐term management for these patients. OBJECTIVE: The aim of this review was to describe the otologic and vestibular symptoms that present in patients with COVID‐19. The primary outcomes of this review were onset, duration and clinical outcomes of these symptoms. SOURCES OF EVIDENCE: Pub Med, APAMed Central, Herdin, CINAHL, Scopus, Springer Link, ProQuest Coronavirus Research Database, and Google Scholar were searched for the articles to be included. ELIGIBILITY CRITERIA: Studies included were those involving adult patients diagnosed with COVID‐19 who experienced hearing loss, ear pain, ear discharge, otitis media, vertigo, or tinnitus. Studies were eligible for inclusion if there was a description of the otologic dysfunction, specifically onset, duration, or clinical outcomes. RESULTS: The majority of patients who experienced hearing loss (68%), tinnitus (88%), vertigo/dizziness (30%), ear pain (8%), and discharge (100%) did so within a month of experiencing the typical symptoms of COVID‐19. A majority also experienced complete resolution of their symptoms within 2 weeks. Standard treatment for COVID‐19 was usually provided but when specific diagnoses are made for these symptoms (e.g., sudden sensorineural hearing loss, otitis media, vestibular neuritis), they are treated in the same manner as one would for non‐COVID‐19 cases, in addition to the management for COVID‐19. In certain cases, there may be a need for additional work‐up to rule out other causes. CONCLUSIONS: Otologic and vestibular symptoms were present in COVID‐19 patients, majority as part of the systemic nature of the disease. The onset, duration, and course were consistent with the natural history of a systemic viral infection. COVID‐19 should be considered in any patient with a new‐onset hearing loss, tinnitus, or vertigo/dizziness, even in the absence of infectious or respiratory symptoms. Coronavirus 2019, more commonly known as COVID-19, is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The most common presenting symptoms of this condition are fever, cough, and fatigue. 1 On the other hand, sore throat, headache, and smell affectations are the most common ear nose and throat (ENT) manifestations in patients with COVID-19. 2 However, there have been reports suggesting that the spectrum of clinical presentation may be wider than initially thought, to even include problems in hearing and other otologic conditions. Reviews by Almufarrij and Munro in 2021 3 and Maharaj, Alvarez, Mungul, and Hari in September 2020 4 showed that, though relatively rare, reports of otologic, audiologic, and vestibular symptoms have been seen in patients confirmed to have COVID-19, particularly, hearing loss, tinnitus, and vertigo. However, further discussion of these symptoms may provide insight into short-and long-term management for similar patients. The aim of this review was to describe the otologic and vestibular symptoms that present in patients with COVID-19. The primary outcomes of this review were onset, duration, and clinical outcomes of these symptoms. Secondary outcome included was describing therapeutic management received by these patients. The preferred reporting items for systematic reviews and metaanalyses extension for scoping reviews (PRISMA-ScR) checklist was followed for this study. 5 This study was registered in the institution's Research Administration Office. As this study is a systematic review of published literature, institutional ethical committee approval and informed consent were not obtained. The population of interest was adult patients who were diagnosed with COVID-19 (SARS-CoV-2) using any diagnostic tool available for this disease (antigen test, antibody test, real-time polymerase chain reaction [RT-PCR]). The patients experienced or were diagnosed with the following: hearing loss, ear pain, ear discharge, otitis media, vertigo, or tinnitus. Studies were eligible for inclusion if there was a description of the otologic dysfunction, specifically onset, duration, or clinical outcomes. Randomized and nonrandomized controlled trials, cohort, case-control, cross-sectional, case series, and case reports were included. Studies involving the pediatric population were excluded. Studies were also excluded if the description of the specific dysfunction was inadequate, did not have a description on at least one of the primary outcomes, or there were no original case descriptions. Articles that were not in English were translated using Google Translate and were still included if they fulfilled the other criteria mentioned. and T. L. G. C.). The following terms were used in the search "COVID-19" or "SARS-CoV-2" or "coronavirus," or "NCoV-19," and "hearing loss" or "ear pain" or "otalgia" or "ear discharge" or "otorrhea" or "otitis media" or "vertigo" or "tinnitus" or "otologic" or "neurotologic" or "audiologic" or "vestibular." Search strategies were adjusted to suit each database. Citations were screened for any additional relevant articles. We also considered other article types such as letters to the editor and brief communications or correspondence. Preprint articles were included to increase the sample size. Grossly irrelevant articles were removed. Retrieved references were checked for duplications and thus removed. The full text of the remaining studies was screened independently by both authors using the eligibility criteria as discussed above. Any disagreement regarding eligibility was resolved through a discussion. Quality assessment of the included studies was evaluated by two investigators (K. M. C. O. and T. L. G. C.) using the Murad tool. 6 We considered poor, fair, and good quality if the average rating for each study was less than 3, less than 5, or 5 and above, respectively. Any disagreement was resolved by the investigators through a discussion. The following data were extracted from the full text of the articles: author and year, study design, setting, number of patients of interest, age/age range, sex, otologic/vestibular signs and symptoms, and other relevant clinical information on patients (comorbidities, onset of symptoms, duration of symptoms, treatment for the otologic/ vestibular dysfunction, clinical outcome). Categorical variables were pooled as frequencies and percentages while continuous variables were summarized using means or medians with standard deviation or ranges when deemed possible. The systematic literature search strategy performed on February 6, 2021, yielded a total of 1409 studies. We excluded 1270 for lack of relevance, 55 articles were found to be duplicates. Of the remaining 84 studies whose abstracts were screened, 52 did not contain information on the primary outcome of interest. Another seven articles were excluded either because the full text could not be found, or the article was on the pediatric population. Only 25 articles fulfilled the eligibility criteria. An additional six articles were added after doing an updated search on April 11, 2021. Eleven articles were also included after looking through citations. Figure 1 shows the flow diagram, including the reasons for the exclusion of articles. Quality assessment of sources of evidence Table 1 shows the quality assessment of the studies included. The studies were assessed as fair to good in quality. Details of hearing loss were present in 23 published reports, comprised of 199 patients. 7, 9, 11, 13, 17, [21] [22] [23] [25] [26] [27] [28] [30] [31] [32] [34] [35] [36] [37] 39, 41, 43, 45 Almost 68% of these patients began experiencing hearing loss within a month from the onset of typical symptoms or from COVID-19 diagnosis. Only three patients (1.5%) experienced hearing loss with no other symptom and were tested for COVID-19 sometime later. 11, 30, 37 One patient did not report hearing loss as a symptom but with significant audiometry findings. Three patients (1.5%) experienced hearing loss more than a month after being diagnosed with COVID-19, ranging from 40 to 117 days. 7, 41, 45 The remaining 28.6% did not provide any details regarding onset. Twelve patients from case reports provided details of their audiometry. All three patients diagnosed with otitis media presented with unilateral hearing loss-two had mild conductive hearing loss, while one had moderate mixed hearing loss. 21, 22, 30 Nine patients were diagnosed with sensorineural hearing loss-five bilateral, four unilateral-with varying severity. Two of these cases presented with low-frequency hearing loss, 13 18 report two cases that were resolved after more than a month. Dizziness can occur as long as 4 months as reported by Garcia-Romo et al. 29 . Symptoms were persistent in seven patients (5.3%). 24 experienced persistent ear pain. The timing of the assessment ranged from at least a week from the resolution of general symptoms to as long as 6 months. 24, 40, 47 The remaining 10% had insufficient details. 12, 21 The two most common diagnoses for ear pain were acute otitis externa and otitis media, with nearly all cases attributed to the COVID-19 diagnosis. Limited information was mentioned regarding otologic-specific management in most cases, but in those that provided some information, systemic antibiotic and antiviral medication, 21 these can still be significant concerns for the patients, and will need appropriate management. Our current study was a review of available literature aimed to describe COVID-19 associated otologic and vestibular symptoms in terms of onset, duration, and recovery, to provide insight on how best to manage these patients. Hearing loss, when it occurred, had an onset within a month from the initial typical symptoms of COVID-19 for 68% of the patients. Ninety percent of the patients who fully recovered did so within 2 weeks of the onset. Hearing loss was considered as an associated symptom of COVID-19 for most of the cases and did not receive any specific treatment. The onset and duration of hearing loss, when considered as a component of COVID-19, was consistent with the more than half-a-century old concept that the general natural history of a respiratory viral infection is that symptoms resolve within 2 weeks from the onset. 53 In cases where the hearing loss was rendered a specific diagnosis rather than just being a part COVID-19, SSNHL, and otitis media were the most common distinct otologic diagnosis made and given appropriate management. Sensorineural hearing affectation appeared to be more common and tended to be more severe than conductive hearing loss in patients with COVID-19. Affected frequencies in the pure tone audiometry of these patients were varied with low-frequency, high-frequency, and global hearing loss patterns seen. A study by Mustafa 54 on asymptomatic patients that tested COVID-19 positive, however, showed that highfrequency thresholds were significantly lower than a control group of normal-hearing patients. Tinnitus, when it occurred, had an onset within a month in 88% of the patients. The majority of the tinnitus cases were considered part of COVID-19 and although detailed information was not available, it is significant to note that half of the patients with complete recovery also did so within 2 weeks, just like hearing loss. Information on the onset of vertigo and dizziness in COVID-19 was scarce. When available, it also occurred within a month after the onset of the initial typical symptoms. It is important to note that, although relatively uncommon, these can be the presenting symptom The studies included were prone to recall and reporting bias. Some of the studies, particularly the cross-sectional studies, were designed such that patients were asked to recall their symptoms ONG ET AL. | 7 retrospectively, which affected the completeness and accuracy of the reports. The use of self-reported symptoms for some studies, rather than the use of more objective tests such as audiometry may have also led to underreporting. In addition, authors were more likely to report symptoms as COVID-19 associated if they occurred shortly before or after the onset of the typical symptoms of COVID-19. Isolated otologic and vestibular symptoms were less likely to be tested for and, therefore, associated with COVID-19, which prevented characterization of these cases in terms of onset, duration, and recovery. The studies were also different in their definitions for persistent symptoms as they were based primarily on when the study was performed or when the patients were last followed up, which ranged between a few weeks to 6 months. Long-term sequelae of these symptoms were also not determined. Our search strategy was also limited to studies that mentioned "vestibular" or "vertigo" symptoms to exclude studies that discussed nonspecific or other causes of dizziness (such as neurologic or cardiac The authors declare no conflicts of interest. The data that support the findings of this study are available from the corresponding author upon reasonable request. As this study is a systematic review of published literature, institutional ethical committee approval and informed consent were not obtained. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): a systematic review and meta-analysis of 148 studies from 9 countries ENT manifestation in COVID-19 patients One year on: an updated systematic review of SARS-CoV-2, COVID-19 and audio-vestibular symptoms Otologic dysfunction in patients with COVID-19: a systematic review PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation Methodological quality and synthesis of case series and case reports Autologous hematopoietic transplantation following COVID-19 infection Neurosensory dysfunction: a diagnostic marker of early COVID-19 Sudden sensorineural hearing loss in COVID-19: a case report and literature review 18F-FDG PET/CT and serial chest CT findings in a COVID-19 patient with dynamic clinical characteristics in different period Bilateral sudden sensorineural hearing loss and intralabyrinthine hemorrhage in a patient with COVID-19 Increased incidence of otitis externa in covid-19 patients COVID-19 and tinnitus Congenital inner ear abnormalities and COVID-19-related ear infections Approaching otolaryngology patients during the COVID-19 pandemic A case of COVID-19-induced vestibular neuritis Acute profound sensorineural hearing loss after COVID-19 pneumonia A case series of vestibular symptoms in positive or suspected COVID-19 patients A first case of acute cerebellitis associated with coronavirus disease (COVID-19): a case report and literature review Critical alert for otolaryngologists: earache may be the early signs of COVID-19 New type of corona virus induced acute otitis media in adult Considerations in management of acute otitis media in the COVID-19 era Rised sudden sensorineural hearing loss during COVID-19 widespread Delayed symptoms in patients recovered from COVID-19 Symptomatology in head and neck district in coronavirus disease (COVID-19): a possible neuroinvasive action of SARS-CoV-2 Persistent selfreported changes in hearing and tinnitus in post-hospitalisation COVID-19 cases Audiovestibular symptoms and sequelae in COVID-19 patients Acute labyrinthitis revealing COVID-19. Diagnostics (Basel) COVID-19 presenting with nystagmus Otitis media in coronavirus disease 2019: a case series Sudden sensorineural hearing loss and SARS-CoV-2: Don’t forget the standard workup COVID -19 and sudden sensorineural hearing loss, a case report The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019 Symptomatology of COVID-19 from the otorhinolaryngology perspective: a survey of 223 SARS-CoV-2 RNA-positive patients Novel ENT triad of anosmia, ageusia and hearing impairment in COVID-19 Prevalence of otorhinolaryngological symptoms in covid 19 patients Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss Dizziness can be an early sole clinical manifestation for COVID-19 infection: a case report Otolaryngological manifestations of hospitalised patients with confirmed COVID-19 infection Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study Sudden irreversible hearing loss post COVID-19 COVID-19-induced vestibular neuritis, hemi-facial spasms and Raynaud's phenomenon: a case report A 67-year-old woman with sudden hearing loss associated with SARS-CoV-2 infection Tinnitus and equilibrium disorders in COVID-19 patients: preliminary results Coronavirus disease 2019 and sudden sensorineural hearing loss COVID-19 sampling from the middle ear and mastoid: a case report Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019 A novel coronavirus pneumonia case report from an ear, nose, and throat clinic COVID-19 pathophysiology: a review Role of viral infection in sudden hearing loss Viral causes of hearing loss: a review for hearing health professionals Vestibular neuronitis Rhinovirus infections in an industrial population: II. Characteristics of illness and antibody response Audiological profile of asymptomatic Covid-19 PCRpositive cases Otologic and vestibular symptoms in COVID-19: a scoping review